Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abiomed Inc
(NQ:
ABMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Abiomed Inc
< Previous
1
2
Next >
FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
December 21, 2022
From
Abiomed, Inc.
Via
Business Wire
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
December 09, 2022
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.
Via
MarketBeat
First Patients in the World Treated with Impella RP Flex with SmartAssist
December 05, 2022
From
Abiomed, Inc.
Via
Business Wire
ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD
November 16, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
S&P 500 Component DexCom Set For Further Price, Earnings Growth
November 13, 2022
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)
November 08, 2022
From
Brodsky & Smith LLC
Via
GlobeNewswire
ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD
November 01, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Johnson & Johnson (NYSE: JNJ) Set to Acquire Abiomed (NASDAQ: ABMD) for $16.6 Billion or $380 per Share Plus CVR
November 01, 2022
Abiomed, Inc. (NASDAQ: ABMD) is engaged as a medical technology company, which is focused on providing support and resources to
Via
Spotlight Growth
Exposures
Product Safety
ABMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ABIOMED, Inc. Is Fair to Shareholders
November 01, 2022
From
Halper Sadeh LLC
Via
Business Wire
Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year
November 01, 2022
From
Abiomed, Inc.
Via
Business Wire
Johnson & Johnson to Acquire Abiomed
November 01, 2022
From
Johnson & Johnson
Via
Business Wire
Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
October 31, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare
October 26, 2022
From
Abiomed, Inc.
Via
Business Wire
MedTechVets Appoints Patrice Sutherland, Enterprise Executive Director at Integra LifeScience, as New Board Chairperson
October 24, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure
October 20, 2022
From
Abiomed, Inc.
Via
Business Wire
U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath
October 17, 2022
From
Abiomed, Inc.
Via
Business Wire
Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support
October 13, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed Second Quarter Fiscal 2023 Earnings and Conference Call Notification
October 13, 2022
From
Abiomed, Inc.
Via
Business Wire
Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%
September 20, 2022
From
Abiomed, Inc.
Via
Business Wire
Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81%
September 19, 2022
From
Abiomed, Inc.
Via
Business Wire
Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients
September 17, 2022
From
Abiomed, Inc.
Via
Business Wire
FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)
September 16, 2022
From
Abiomed, Inc.
Via
Business Wire
TCT 2022: Impella Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery
September 13, 2022
From
Abiomed, Inc.
Via
Business Wire
Restore EF Study Shows Heart Function, Symptom Improvements for High-Risk PCI Patients Supported by Impella
August 16, 2022
From
Abiomed
Via
Business Wire
ABIOMED Announces First Quarter Record Revenue of $277 Million, up 10% Year Over Year, up 12% in Constant Currency*
August 04, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification
July 14, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed to Host Investor Call on Heart Failure Opportunity With Impella 5.5 and Impella BTR Heart Pumps
June 14, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference
May 31, 2022
From
Abiomed, Inc.
Via
Business Wire
SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes
May 18, 2022
From
Abiomed
Via
Business Wire
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year
April 28, 2022
From
Abiomed, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.